TrialJAMA ophthalmology2013

Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.

Diabetic Retinopathy Clinical Research Network*PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.